These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 1327501)
1. Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier. Juweid M; Neumann R; Paik C; Perez-Bacete MJ; Sato J; van Osdol W; Weinstein JN Cancer Res; 1992 Oct; 52(19):5144-53. PubMed ID: 1327501 [TBL] [Abstract][Full Text] [Related]
2. Early intervention in cancer using monoclonal antibodies and other biological ligands: micropharmacology and the "binding site barrier". Weinstein JN; van Osdol W Cancer Res; 1992 May; 52(9 Suppl):2747s-2751s. PubMed ID: 1563006 [TBL] [Abstract][Full Text] [Related]
3. An analysis of monoclonal antibody distribution in microscopic tumor nodules: consequences of a "binding site barrier". van Osdol W; Fujimori K; Weinstein JN Cancer Res; 1991 Sep; 51(18):4776-84. PubMed ID: 1893370 [TBL] [Abstract][Full Text] [Related]
4. A quantitative analysis of tumor specific monoclonal antibody uptake by human melanoma xenografts: effects of antibody immunological properties and tumor antigen expression levels. Shockley TR; Lin K; Sung C; Nagy JA; Tompkins RG; Dedrick RL; Dvorak HF; Yarmush ML Cancer Res; 1992 Jan; 52(2):357-66. PubMed ID: 1728407 [TBL] [Abstract][Full Text] [Related]
5. Spatial distribution of tumor-specific monoclonal antibodies in human melanoma xenografts. Shockley TR; Lin K; Nagy JA; Tompkins RG; Yarmush ML; Dvorak HF Cancer Res; 1992 Jan; 52(2):367-76. PubMed ID: 1728408 [TBL] [Abstract][Full Text] [Related]
6. Predicted and observed effects of antibody affinity and antigen density on monoclonal antibody uptake in solid tumors. Sung C; Shockley TR; Morrison PF; Dvorak HF; Yarmush ML; Dedrick RL Cancer Res; 1992 Jan; 52(2):377-84. PubMed ID: 1728409 [TBL] [Abstract][Full Text] [Related]
7. Regional and systemic distribution of anti-tumor x anti-CD3 heteroaggregate antibodies and cultured human peripheral blood lymphocytes in a human colon cancer xenograft. Nelson H; Ramsey PS; Kerr LA; McKean DJ; Donohue JH J Immunol; 1990 Nov; 145(10):3507-15. PubMed ID: 1700013 [TBL] [Abstract][Full Text] [Related]
8. Penetration and binding of antibodies in experimental human solid tumors grown in mice. Ong GL; Mattes MJ Cancer Res; 1989 Aug; 49(15):4264-73. PubMed ID: 2743313 [TBL] [Abstract][Full Text] [Related]
9. Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies. Blumenthal RD; Sharkey RM; Haywood L; Natale AM; Wong GY; Siegel JA; Kennel SJ; Goldenberg DM Cancer Res; 1992 Nov; 52(21):6036-44. PubMed ID: 1394228 [TBL] [Abstract][Full Text] [Related]
10. Microdistribution of specific rat monoclonal antibodies to mouse tissues and human tumor xenografts. Kennel SJ; Falcioni R; Wesley JW Cancer Res; 1991 Mar; 51(5):1529-36. PubMed ID: 1997194 [TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody SEN7 recognizes a new epitope on the neural cell adhesion molecule present on small cell lung cancer but not on lymphocytes. Waibel R; Mannhart M; O'Hara CJ; Brocklehurst C; Zangemeister-Wittke U; Schenker T; Lehmann HP; Weber E; Stahel RA Cancer Res; 1993 Jun; 53(12):2840-5. PubMed ID: 7684948 [TBL] [Abstract][Full Text] [Related]
12. Compartmental distribution of tumor-specific monoclonal antibodies in human melanoma xenografts. Lin K; Nagy JA; Xu H; Shockley TR; Yarmush ML; Dvorak HF Cancer Res; 1994 Apr; 54(8):2269-77. PubMed ID: 8174137 [TBL] [Abstract][Full Text] [Related]
13. Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Yokota T; Milenic DE; Whitlow M; Schlom J Cancer Res; 1992 Jun; 52(12):3402-8. PubMed ID: 1596900 [TBL] [Abstract][Full Text] [Related]
14. Modeling analysis of the global and microscopic distribution of immunoglobulin G, F(ab')2, and Fab in tumors. Fujimori K; Covell DG; Fletcher JE; Weinstein JN Cancer Res; 1989 Oct; 49(20):5656-63. PubMed ID: 2790783 [TBL] [Abstract][Full Text] [Related]
15. A modeling analysis of monoclonal antibody percolation through tumors: a binding-site barrier. Fujimori K; Covell DG; Fletcher JE; Weinstein JN J Nucl Med; 1990 Jul; 31(7):1191-8. PubMed ID: 2362198 [TBL] [Abstract][Full Text] [Related]
16. Combined immunohistochemical and autoradiographic analyses of antigen/antibody interactions in tumor xenograft models. DePalatis LR; Johnson KA; Kaplan DA Lab Invest; 1991 Jul; 65(1):111-20. PubMed ID: 2072661 [TBL] [Abstract][Full Text] [Related]
17. Integrated microscopic-macroscopic pharmacology of monoclonal antibody radioconjugates: the radiation dose distribution. Fujimori K; Fisher DR; Weinstein JN Cancer Res; 1991 Sep; 51(18):4821-7. PubMed ID: 1893374 [TBL] [Abstract][Full Text] [Related]
18. Radioimmunotherapy of human colon cancer xenografts using a dimeric single-chain Fv antibody construct. Pavlinkova G; Booth BJ; Batra SK; Colcher D Clin Cancer Res; 1999 Sep; 5(9):2613-9. PubMed ID: 10499640 [TBL] [Abstract][Full Text] [Related]
19. Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms. Yokota T; Milenic DE; Whitlow M; Wood JF; Hubert SL; Schlom J Cancer Res; 1993 Aug; 53(16):3776-83. PubMed ID: 8339291 [TBL] [Abstract][Full Text] [Related]
20. Molecules recognized by anti-idiotypic monoclonal antibodies to the B cell lymphoma, BCL1. Tamura GS; McGrath MS; Weissman IL J Mol Cell Immunol; 1987; 3(4):243-53. PubMed ID: 3509925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]